Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 31 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

8%

1 of 13 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (16)

Trial Status

Completed13
Recruiting6
Unknown5
Active Not Recruiting5
Not Yet Recruiting2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (31)

Showing 20 of 20 trials
NCT05239364Not ApplicableRecruiting

Ablation of Consecutive Atrial Tachycardia

NCT03209583Recruiting

ATrial Tachycardia PAcing Therapy in Congenital Heart

NCT05014802Recruiting

Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

NCT07239804Active Not RecruitingPrimary

Systematic Assessment of Treatment Effectiveness for Long-Term Management of Stable Atrial Tachycardia in Inpatient and Outpatient Environments

NCT05434650Active Not Recruiting

Abbott Atrial Fibrillation Post Approval Study

NCT03915691Not ApplicableActive Not RecruitingPrimary

The RIPPLE AT-PLUS Study

NCT07109141Recruiting

Registry of Atrial Arrhythmia Ablation Procedures Using Pulsed Field Ablation in Poland

NCT07079813Not ApplicableNot Yet Recruiting

Clinical Study on the Efficiency of Rapid Arrhythmia Mapping Using EasyStars™ High Density Mapping Catheter Applications

NCT06969378Not ApplicableNot Yet Recruiting

Empiric Pulsed Field Pulmonary Vein Isolation During Atrial Tachycardia Ablation in Adults With Congenital Heart Disease

NCT05883631Not ApplicableActive Not Recruiting

RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.

NCT05521451Recruiting

Clinical Cohort Study - TRUST

NCT03549806Completed

Stanford Cardiac Invasive Electrophysiology Novel Computer Experience

NCT06327425Not ApplicableRecruiting

MCG for Localization of Tachyarrhythmia's Origin

NCT05526170Active Not Recruiting

Triggers and Risk Factors for Recurrence of Atrial Arrhythmias With the Use of Long-term Monitoring

NCT05802576Completed

Study of Interference Between Oral Anticoagulants and Heparin During Ablation of Atrial Fibrillation (AF) or Left Atrial Tachycardia (GAD) by Catheter.

NCT06335446CompletedPrimary

Identification, Electro-mechanical Characterisation and Ablation of Driver Regions in Persistent Atrial Fibrillation

NCT05344456Not ApplicableCompletedPrimary

PVC Response ''Atrial Pace'' Inducing Atrial Tachycardias

NCT03151278Not ApplicableCompleted

Zero Fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for Right Atrial Arrhythmias

NCT05362656Not ApplicableCompleted

AutoMatic disPERsion Tagging Function Preliminary Evaluation

NCT05765565Not ApplicableUnknownPrimary

Comparison Between the Octaray and Pentaray Catheters in Patients Undergoing Ablation for Atrial Tachycardia.

Scroll to load more

Research Network

Activity Timeline